RSS   Newsletter   Contact   Advertise with us

WHO chooses Malaysia for medical trials of Remdesevir against coronavirus

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | March 29, 2020
Malaysia was chosen by the World Health Organization as one of the countries to conduct medical trials of a medicine called Remdesevir on coronavirus patients, as stated by the National Security Council.
Noor Hisham Abdullah
Director General of Health   Noor Hisham Abdullah
As per the entity, the choice was made due to the capability exhibited by the Ministry of Health to conduct the research.

Topics: WHO Malaysia Remdesevir coronavirus

Director General of Health, Noor Hisham Abdullah, said patients of Covid-19 will be treated with Remdesevir, and all side effects and its effectiveness will be controlled.

The WHO announced a great global trial under the name 'Solidarity,' to discover if any medicine can deal with the infection.

The study, which might include thousands of patients in dozens of countries, has been designed to be as simple as possible, so that even hospitals overwhelmed by an avalanche of Covid-19 patients can participate, said Abdullah.

The WHO is centering in what are said to be the four most promising therapies: the experimental antiviral compound Remdesivir, the medicines against malaria Cloroquine and Hidroxicloroquine; a combination of two HIV drugs, Lopinavir and Ritonavir; and the same combination of the two plus Interferon, a stimulant of the immune system.